Mobile-health Network Solutions PE Ratio 2023-2023 | MNDR

Current and historical p/e ratio for Mobile-health Network Solutions (MNDR) from 2023 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Mobile-health Network Solutions PE ratio as of July 04, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Mobile-health Network Solutions PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-03 1.11 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.003B $0.014B
Mobile-health Network Solutions is a telehealth solutions provider principally in Singapore. The company offer users with a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to user homes, as well as other personalized services such as weight management programs. Mobile-health Network Solutions is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.456B 59.10
Doximity (DOCS) United States $11.587B 53.64
Hims & Hers Health (HIMS) United States $10.739B 111.58
Tempus AI (TEM) United States $10.555B 0.00
IRhythm Technologies (IRTC) United States $4.548B 0.00
Inspire Medical Systems (INSP) United States $3.789B 59.21
Hinge Health (HNGE) United States $3.638B 0.00
Privia Health (PRVA) United States $2.696B 184.25
Enovis (ENOV) United States $1.922B 10.72
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.602B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Azenta (AZTA) United States $1.521B 70.70
Omnicell (OMCL) United States $1.398B 24.66
Evolent Health (EVH) United States $1.384B 117.90
Clover Health Investments (CLOV) United States $1.303B 0.00
Claritev (CTEV) United States $0.747B 0.00
Fulgent Genetics (FLGT) United States $0.611B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.513B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.463B 138.50
Outset Medical (OM) United States $0.370B 0.00
TruBridge (TBRG) United States $0.343B 761.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
American Well (AMWL) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.126B 0.00
Pulmonx (LUNG) United States $0.112B 0.00
CareCloud (CCLD) United States $0.104B 3.97
MDxHealth SA (MDXH) Belgium $0.104B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
111 (YI) China $0.064B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.060B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.044B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00